Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
BSTC [NASD]
BioSpecifics Technologies Corp.
Index- P/E30.37 EPS (ttm)0.52 Insider Own3.49% Shs Outstand6.35M Perf Week1.74%
Market Cap100.27M Forward P/E39.47 EPS next Y0.40 Insider Trans329.36% Shs Float4.07M Perf Month-3.72%
Income3.59M PEG1.17 EPS next Q0.07 Inst Own40.04% Short Float2.58% Perf Quarter3.88%
Sales12.54M P/S8.00 EPS this Y-55.03% Inst Trans-0.39% Short Ratio6.77 Perf Half Y17.92%
Book/sh2.93 P/B5.39 EPS next Y73.20% ROA18.49% Target Price33.00 Perf Year0.25%
Cash/sh1.92 P/C8.21 EPS next 5Y26.00% ROE20.96% 52W Range12.52 - 21.99 Perf YTD5.62%
Dividend- P/FCF44.76 EPS past 5Y0.00% ROI20.69% 52W High-28.38% Beta0.60
Dividend %- Quick Ratio- Sales past 5Y49.05% Gross Margin- 52W Low25.80% ATR0.49
Employees5 Current Ratio12.16 Sales Q/Q53.86% Oper. Margin47.36% RSI (14)46.85 Volatility2.03% 2.66%
OptionableNo Debt/Eq0.00 EPS Q/Q82.65% Profit Margin28.65% Rel Volume0.27 Prev Close15.79
ShortableYes LT Debt/Eq0.00 EarningsMay 10 Payout0.00% Avg Volume15.51K Price15.75
Recom1.70 SMA20-0.18% SMA50-3.55% SMA200-3.50% Volume2,916 Change-0.25%
05-Apr-12Initiated MKM Partners Buy $26.50
15-Mar-12Initiated Stifel Nicolaus Buy $29
15-Jun-09Initiated Hapoalim Outperform $40
20-May-13 09:41AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
17-May-13 01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
13-May-13 08:35AM  Company News for May 13, 2013 Zacks
10-May-13 05:29PM  BioSpecifics Technologies' Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
10:12AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
07:30AM  BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial Results PR Newswire
07:07AM  Q1 2013 Biospecifics Technologies Earnings Release - Time Not Supplied CCBN
05:42AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
03-May-13 08:00AM  BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013 PR Newswire
18-Apr-13 11:22PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
10-Apr-13 02:28AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
01-Apr-13 05:33PM  Positive Data on BSTC's Xiaflex Zacks
27-Mar-13 07:55AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
26-Mar-13 08:04AM  InPlay: BioSpecifics Tech announces positive top-line data from Xiaflex phase iia study for frozen shoulder Briefing.com
08:00AM  BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX® Phase IIa Study for Frozen Shoulder PR Newswire
21-Mar-13 01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
15-Mar-13 05:11PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-K, Annual Report EDGAR Online
13-Mar-13 06:48PM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
04:15PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
12-Mar-13 05:28PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
04:00PM  BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results PR Newswire
07:07AM  Q4 2012 Biospecifics Technologies Earnings Release - Time Not Supplied CCBN
07-Mar-13 06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:16PM  Nasdaq stocks posting largest percentage decreases AP
06-Mar-13 06:01AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
05-Mar-13 04:31PM  BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, March 12, 2013 PR Newswire
01-Mar-13 05:13PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events EDGAR Online
27-Feb-13 04:41PM  BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences PR Newswire
05-Feb-13 04:57PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04-Feb-13 04:35PM  BioSpecifics says journal details IMPRESS trials at theflyonthewall.com
04:33PM  InPlay: BioSpecifics Tech announces online publication in The Journal of Urology of results from the IMPRESS trials of XIAFLEX in Peyronie's Disease Briefing.com
04:30PM  BioSpecifics Technologies Corp. Announces Online Publication in The Journal of Urology of Results from the IMPRESS Trials of XIAFLEX® in Peyronie's Disease PR Newswire
22-Jan-13 05:25PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
11-Jan-13 01:44AM  [$$] Auxilium Pharma Loses Some Power at Barrons.com
07-Jan-13 04:42PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:41PM  Auxilium Moves Forward on Potential Anti-Cellulite Drug at Motley Fool
12:59PM  Auxilium expands license for cellulite treatment AP
09:39AM  Cellulite control could be lucrative market for Auxilium at bizjournals.com
08:04AM  InPlay: BioSpecifics Tech announces XIAFLEX progress in two pipeline indications; FDA accepts supplemental biologics license application filing for treatment of Peyronie's Disease Briefing.com
08:00AM  BioSpecifics Technologies Corp. Announces XIAFLEX® Progress in Two Pipeline Indications PR Newswire
04-Jan-13 01:53PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
17-Dec-12 05:27PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
13-Dec-12 04:50PM  BioSpecifics Technologies Corp. Announces Top-Line 30-Day Data from XIAFLEX® Phase Ib Study for Treatment of Cellulite PR Newswire
10-Dec-12 10:00AM  BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com PR Newswire
04-Dec-12 02:28PM  BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th PR Newswire
03-Dec-12 01:19PM  Executives From NYSE, NASDAQ and OTC Markets Companies Embrace Transparency Towards Investors at December 6th RetailInvestorConferences.com PR Newswire
16-Nov-12 01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
15-Nov-12 11:38AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  InPlay: BioSpecifics Tech announces board authorization of up to $2 million stock repurchase program Briefing.com
08:00AM  BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Stock Repurchase Program PR Newswire
13-Nov-12 01:27PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
10-Nov-12 09:29AM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
09-Nov-12 01:17PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
09:32AM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
08-Nov-12 05:25PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan EDGAR Online
04:01PM  BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results PR Newswire
03:04PM  Weak Quarter from Auxilium Pharma Zacks
07-Nov-12 05:22PM  InPlay: BioSpecifics Tech announces submision of sBLA for XIAFLEX for treatment of Peyronie's disease Briefing.com -8.15%
05:18PM  BioSpecifics Technologies Corp. Announces Submission of Supplemental Biologics License Application to FDA for XIAFLEX® for Treatment of Peyronie's Disease PR Newswire
01-Nov-12 04:30PM  BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012 PR Newswire
22-Sep-12 09:09AM  5 Low-Debt Biotech Stocks Forecasted For Growth at Seeking Alpha
13-Sep-12 08:00AM  BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference PR Newswire +6.95%
06-Sep-12 04:38PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05-Sep-12 04:30PM  BioSpecifics Technologies Corp. Announces 30 Month Safety Update for XIAFLEX® in Dupuytren's Contracture PR Newswire
04-Sep-12 12:36PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08:00AM  BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September PR Newswire
29-Aug-12 10:21AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012 PR Newswire
27-Aug-12 05:57PM  BioSpecifics announces presentation of additional Phase III data theflyonthewall.com
05:43PM  BioSpecifics Technologies Corp. Announces Presentation of Additional Phase III Data from XIAFLEX® Clinical Trials for Peyronie's Disease at SMSNA/ISSM Joint Annual Meeting PR Newswire
23-Aug-12 04:19PM  8 Highly Liquid Healthcare Stocks Undervalued By EPS Trends at Seeking Alpha
17-Aug-12 01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
02:40AM  5 Profit-Generating Biotech Stocks That Analysts Love at Seeking Alpha
16-Aug-12 10:17AM  Equity Briefing: Upgrades and Downgrades for August 16th: ABC, ABFS, ACHN, ALE, AMAT, ANF, AVNW, AXP, BEAV Thomson Reuters ONE
13-Aug-12 06:02AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
10-Aug-12 10:26AM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
09-Aug-12 10:08AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
07:30AM  BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results PR Newswire
07:07AM  Q2 2012 Biospecifics Technologies Earnings Release - Before Market Open CCBN
02-Aug-12 08:44AM  A Profitable Quarter for Auxilium Zacks
08:00AM  BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012 PR Newswire
18-Jul-12 12:44PM  5 Analyst-Backed Healthcare Small Caps Commanding Strong Profits at Seeking Alpha
06-Jul-12 11:25AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
27-Jun-12 05:24PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
26-Jun-12 04:31PM  InPlay: BioSpecifics Technologies announces initiation of XIAFLEX Phase II trial for human lipomas Briefing.com
04:30PM  BioSpecifics Technologies Corp. Announces Initiation of XIAFLEX® Phase II Trial for Human Lipomas PR Newswire
22-Jun-12 04:31PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
11-Jun-12 03:37PM  7 Growing Biotech Small Caps With Strong Analyst Confidence at Seeking Alpha
07-Jun-12 10:38AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
06-Jun-12 11:51AM  Catalyst And Questions For 2 Biotech Movers at Seeking Alpha
05-Jun-12 06:04AM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04-Jun-12 05:20PM  BioSpecifics Technologies Corp. to Present at Jefferies 2012 Global Healthcare Conference PR Newswire +5.20%
05:11PM  BioSpecifics Technologies Corp. Announces Positive Top-Line Phase III Data from XIAFLEX® Clinical Trials for Treatment of Peyronie's Disease PR Newswire
17-May-12 04:39PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
01:04PM  BIOSPECIFICS TECHNOLOGIES CORP Financials EDGAR Online Financials
14-May-12 09:30AM  Loss Narrows at Auxilium Zacks +6.18%
12-May-12 10:20AM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
11-May-12 10:03AM  New Star Analyst Rankings for BioSpecifics Technologies Corp StarMine
10-May-12 04:39PM  BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online +7.14%
04:00PM  BioSpecifics Technologies Corp. Reports First Quarter 2012 Financial Results PR Newswire
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase for various clinical indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of adult Dupuytren's contracture patients with a palpable cord. The company also develops XIAFLEX injectable collagenase for Peyronie's disease, frozen shoulder, cellulite, human lipoma, and canine lipoma indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. to develop, market, and sell injectable collagenase. The company was founded in 1957 and is headquartered in Lynbrook, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vogel Jeffrey Kenneth10% OwnerJan 16Sale0.019,00090676,381Mar 18 04:20 PM
Vogel Jeffrey Kenneth10% OwnerDec 27Buy14.07178,2652,508,189685,381Mar 18 04:20 PM
Wegman ThomasPresidentSep 19Option Exercise1.0045,00045,000208,644Sep 21 07:12 PM
Morgan HenryDirectorSep 14Option Exercise1.005,4255,42537,193Sep 18 06:14 PM
Vogel Jeffrey Kenneth10% OwnerAug 15Sale0.019,75098507,116Mar 18 04:20 PM
Wegman TobyDirectorJun 15Sale18.111,96335,5431,714Jun 18 09:24 PM
Wegman TobyDirectorJun 14Sale18.454,37680,7193,677Jun 18 09:24 PM
Wegman TobyDirectorJun 11Sale18.211,50027,3158,053Jun 13 06:56 PM
Wegman TobyDirectorJun 06Sale17.741011,7929,553Jun 08 09:06 PM
Wegman TobyDirectorJun 04Sale17.351,50026,0319,654Jun 05 06:08 PM
Wegman TobyDirectorJun 01Sale16.751,00016,75011,154Jun 05 06:08 PM
Wegman TobyDirectorMay 30Sale21.102144312,154May 31 09:40 PM
Wegman TobyDirectorMay 29Sale17.001001,70012,175May 31 09:40 PM